Hikma Pharmaceuticals PLC (LON:HIK)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1,650.00
+6.00 (0.36%)
Nov 12, 2026, 4:35 PM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.42 billion as of November 12, 2026. It is the 3,857th most valuable company in the world and the 106th biggest in the United Kingdom. Its market cap has decreased by 3.32% in one year.
Market Cap
3.42B
Enterprise Value
4.69B
Revenue
2.58B
Global Rank
Country Rank
#106 United Kingdom
PE Ratio
12.46
ChartMarket Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.42B, an increase of 628.07%. That is a compound annual growth rate of 9.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 3.42B | -0.39% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.82B |
| HUTCHMED (China) | 1.95B |
| Allergy Therapeutics | 91.82M |
| ECO Animal Health Group | 55.90M |
| Shield Therapeutics | 35.31M |
| Provexis | 20.06M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 836.68K |